Comparison of SARS-CoV-2 Antibody Response After 2-Dose mRNA-1273 vs BNT162b2 Vaccines in Incrementally Immunosuppressed Patients

This cohort study compares the antispike antibody titers of the mRNA-1273 and BNT162b2 vaccines for SARS-CoV-2 in incrementally immunosuppressed patients.

Detalles Bibliográficos
Autores principales: Mitchell, Jonathan, Connolly, Caoilfhionn M., Chiang, Teresa Po-Yu, Alejo, Jennifer L., Werbel, William A., Segev, Dorry L., Massie, Allan B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112067/
https://www.ncbi.nlm.nih.gov/pubmed/35576009
http://dx.doi.org/10.1001/jamanetworkopen.2022.11897
Descripción
Sumario:This cohort study compares the antispike antibody titers of the mRNA-1273 and BNT162b2 vaccines for SARS-CoV-2 in incrementally immunosuppressed patients.

Ejemplares similares